Clinical performance of presbyopia correction with New Multifocal Scleral Lens

Clinical performance of presbyopia correction with New Multifocal Scleral Lens(Onefit Multifocal)

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0004485

Enrollment

Registered

2019-11-29

Start date

2016-12-21

Completion date

Unknown

Last updated

2019-12-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Medical Device : A prospective clinical trial of Onefit™ A - multifocal corneoscleral lens (Blanchard Contact Lens INC.) was conducted on 40 participants with presbyopia. At 4 weeks after corneosclera

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: presbyipia patients with myopia or hyperopia between 44 and 61 years old

Exclusion criteria

Exclusion criteria: 1) patients with a systemic disease, such as diabetes, hypertension, and autoimmune disease. 2) patients allergic to contact lens. 3) patients with a history of eye surgery

Design outcomes

Primary

Measure	Time frame
far distance visual acuity, intermediate distance visual acuity, near distance visual acuity	—

Secondary

Measure	Time frame
conjunctival hyperemia, corneal staining, corneal neovascularization, central corneal thickness, corneal endothelial cell count, tear film break-up time	—

Countries

Korea, Republic of

Contacts

Public ContactSang Wook Jin

Dong-A University

Outcome results